At least 3 months for mNexspike and at least 2 months for Comirnaty, Spikevax, or Nuvaxovid.

Yes, co-administration is a recommended option. When deciding whether to co-administer vaccines, providers should consider the feasibility that the patient can return for additional vaccine doses, risk for acquiring severe disease, vaccine reactogenicity profiles, and patient preferences.

Consider waiting 3 months per CDC guidance. 

Yes. CDPH-recommended vaccines will continue to be covered by health care insurers regulated by the State of California (AB144).